Virtus ETF Advisers’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.56K Hold
25
– – ﹤0.01% 492
2026
Q2
$3.92K Buy
25
+18
+257% +$2.7K ﹤0.01% 490
2026
Q1
$1.07K Hold
7
– – ﹤0.01% 484
2025
Q4
$965 Buy
+7
New +$917 ﹤0.01% 486

Other funds holding NVS

Virtus ETF Advisers's NVS Position: Q3 2026 in Review

Virtus ETF Advisers held its Novartis (NVS) position steady in Q3 2026 at 25 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Virtus ETF Advisers first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.92K in Q2 2026. 995 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Virtus ETF Advisers held 25 shares of Novartis worth $3.56K as of Q3 2026.
  • Virtus ETF Advisers left its Novartis share count unchanged in Q3 2026.
  • Novartis made up ﹤0.01% of Virtus ETF Advisers's portfolio in Q3 2026, its #492 holding.
  • Virtus ETF Advisers first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • Virtus ETF Advisers's Novartis position peaked at $3.92K in Q2 2026.
  • 995 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Virtus ETF Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.